Cancer Vaccines

Technique Topples Barriers: Micrometastases Now Culturable for Vaccines

Published in Cancer Weekly, August 14th, 1995

A recently developed technique now allows researchers to culture the minute amounts of micrometastases available for the development of genetically modified, autologous tumor cell vaccines.

Microscopic metastases are heterogenous cancer cells that have not yet gained the fully autonomous growth potential of mature metastatic cancer. At this stage, these cancer cells are more vulnerable to the patient's intact immune system and are at an idyllic stage for cancer vaccines to be most effective.

Up to this point, it has been extremely difficult to identify such small quantities of cancer cells, much less culture them for the development of autologous...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-08-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry